Thanks to its simple saliva-based approach, the COVID-19 test from Intelligent Fingerprinting is ideal for use by people of all ages – particularly those who find the current testing regime uncomfortable and potentially distressing. Our easy-to-use saliva-based lateral flow test supports a range of applications, including schools, workplaces, universities, care homes, healthcare, and public events.
Our test requires a saliva sample to be taken just from the inside of the cheek – so there’s no need for unpleasant and invasive nose and throat swabs. Watch our video to see how easy it is to conduct a test.
Yes, the SARS-CoV-2 monoclonal antibody we use for antigen detection has been tested against the Omicron Nucleocapsid Protein and our VSS-GP test has strong recognition of this variant.
Yes, our test is CE marked under the In Vitro Diagnostics Directive for professional use and is available to order, subject to appropriate regulatory approval in your country. For more information, call +44 (0)1223 941941 or inquire via our website.
Our test is competitively priced compared with other lateral flow COVID-19 tests. For more information, call +44 (0)1223 941941 or inquire via our website.
To order tests (for professional use only), please call us on +44 (0)1223 941941 or contact us.
Our test is CE marked for professional use only by dedicated testing personnel, rather than for self-testing at home.
The accuracy of our test is similar to other COVID-19 lateral flow tests. Clinical precision testing of Intelligent Fingerprinting’s VSS-GP lateral flow saliva test has resulted in 100% sensitivity and specificity (n = 400 results) using RT-PCR verified samples containing SARS-CoV-2 virus (lowest viral titer Ct 28.5).
Our VSS-GP COVID-19 test strip uses minimal plastic and has none of the plastic housing usually associated with lateral flow tests, helping to significantly reduce waste. In addition, it is around 95% lighter than traditional lateral flow devices, enabling a reduction in the environmental impact of packaging and transportation.
Unlike most, if not all, lateral flow tests available in the UK (which are largely manufactured in the far east) our COVID-19 test has been entirely designed, developed and manufactured in the UK. Intelligent Fingerprinting has been wholly responsible for the product’s development, using our expertise in designing highly sensitive, entirely new lateral flow testing products, such as our unique fingerprint drug tests that are sold in the UK, US and other international markets. We’re set up to produce millions of COVID-19 tests a month at our Cambridge, UK facility.
We are certainly keeping them informed about our test. We believe people are fed up with invasive nose and throat tests, and that our saliva test provides a more attractive alternative.
FDA submission for Emergency Use Authorisation will be progressed in due course.